Home › Kidney Cancer › California › Santa Monica
Kidney Cancer clinical trials in Santa Monica, CA
3 studies for Kidney Cancer are looking for participants at sites in and around Santa Monica (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
RecruitingPhase 1
- Research Site, Santa Monica
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- UCLA Medical Center, Santa Monica
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
RecruitingPhase 1/2
- UCLA Hematology/Oncology - Santa Monica, Santa Monica
- UCLA Hematology/Oncology - Marina del Rey, Marina del Rey · 3 mi away
- UCLA Hematology/Oncology- Encino, Encino · 10 mi away
About Kidney Cancer
Kidney cancer symptoms are hard to detect at first but they do exist. Read more about the top 5 symptoms and the treatment options available
More about Kidney Cancer on MedlinePlus
Kidney Cancer trials in other cities
- New York City, NY16 studies
- Boston, MA11 studies
- Nashville, TN11 studies
- Houston, TX10 studies
- St. Louis, MO10 studies
- Edison, NJ9 studies
- Dallas, TX9 studies
- Washington, DC9 studies
- San Diego, CA9 studies
- Los Angeles, CA8 studies
- Seattle, WA8 studies
- Queens, NY7 studies
Other studies in Santa Monica
- Non-Small Cell Lung Cancer45 studies
- Breast Cancer29 studies
- Cancer (all types)21 studies
- Colorectal Cancer20 studies
- Metastatic Cancer17 studies
- Prostate Cancer15 studies
- Ovarian Cancer14 studies
- Lung Cancer14 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Heart Failure10 studies
- Pancreatic Cancer9 studies
- Liver Cancer (Hepatocellular Carcinoma)9 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.